Predicting dynamic changes of Ki-67 in breast cancer after neoadjuvant therapy based on multi-phase DCE-MRI delta-radiomics
{{output}}
Background: Ki-67 is a key biomarker of tumor proliferation in breast cancer. A reduction in Ki-67 following neoadjuvant therapy (NAT) reflects chemosensitivity and holds significant prognostic value. Therefore, pre-treatment ass... ...
